MONOPAR THERAPEUTICS INC (MNPR) Stock Analyst Ratings
NASDAQ:MNPR - Nasdaq - US61023L2079 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to MNPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 47.43. This target is 17.84% above the current price.
MNPR was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MNPR.
In the previous month the buy percentage consensus was at a similar level.
MNPR was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-10 | Piper Sandler | Initiate | Overweight |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-11 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-11 | JonesTrading | Upgrade | Hold -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-29 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-03-28 | EF Hutton | Maintains | Buy |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-14 | EF Hutton | Reiterate | Buy |
| 2023-01-23 | EF Hutton | Initiate | Buy |
| 2022-12-09 | Roth Capital | Reiterate | Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-01 | HC Wainwright & Co. | Initiate | Buy |